Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

BEAUTY IN THE REAL WORLD.

Until recently, the real world wasn’t usually referred to as such – because it wasn’t referred to much at all. It used to be a given; now it’s just one of the options,something to dip into – perhaps for a packet of Soylent  (or even Soylent ). And to save time when referring to ‘out there’, we have developed the term ITRW, ‘In The Real World’. However, did we manage without it before? Very easily. But reality is good for us. Shared reality, that is. The reality of

BEWi Annual Report 2017

Press release 2018-05-04, 08:00 a.m. CET The BEWi annual report for 2017 is now available in English and Swedish.A digital version can be downloaded at http://bewi.com/en/investors/. A printed version is ordered by calling +46 708 326 854 or by sending an e-mail to lena.olofsdotter@bewi.com. The printed version is estimated to be ready for distribution by beginning of June. For further information contact:  Lena Olofsdotter, Corporate Communications, lena.olofsdotter@bewi.com, or call +46 708 326 854.  BEWi AB (publ) is required to publish the above information under the Swedish

Eco-friendlier Kiilto Freeze -55 °C, Kiilto Leakfinder and Kiilto Pressureclean now available

Developed for professional use, Kiilto Freeze -55 °C, Kiilto Leakfinder and Kiilto Pressureclean aerosols use a new HFO propellant. As a result, these products are eco-friendlier than before, while their properties have remained unchanged.The development of propellants has focused on the reduction of environmental impact since the impact of Freons on the ozone layer was discovered. The HFC propellant used previously in new aerosols was a greener option compared to its predecessors. Thanks to the switch to the use of HFO, the products now have an even lower environmental impact.

Byggmax opened new store in Oslo, Norway

Byggmax opened a new store in Oslo this morning, thus being the first store opening this year in Norway. Byggmax continues to grow and now operates 37 stores in Norway and a total of 138 stores on three markets.Byggmax sells construction materials such as lumber, flooring, dry-wall, cement, windows, doors and paint to both professionals and DIY-customers. The Byggmax concept offers good quality products at low prices. Byggmax is part of Byggmax Group, that also includes Skånska Byggvaror and Buildor AB. The corporate group had a turnover of SEK 5.2 billion in 2016 and Byggmax Group is

Oriola Corporation invests in Swedish online medical center Doktor.se

Oriola Corporation has invested in Swedish online medical center Doktor.se. Oriola has subscribed for shares in Doktor.se giving it an ownership of approximately 17% of the total number of shares in Doktor.se. Doktor.se is the second largest online medical center in Sweden. Oriola and Doktor.se signed a co-operation agreement already last year and through this investment by Oriola the companies will deepen their cooperation.  "Together with Doktor.se we will become even stronger in the fast developing digital healthcare market in Sweden. The services offered together with Doktor.se

Bulletin from the Annual General Meeting in Edgeware AB (publ) on 4 May 2018

The following decisions were passed, among others, at the Annual General Meeting (the “AGM”) in Edgeware AB (publ) on 4 May 2018. The board of directors’ complete proposals have previously been published and is available at the company’s website: corporate.edgeware.tv.Approval of the annual report, appropriation of result and discharge from liability The AGM decided to adopt the income statement and balance sheet, consolidated income statement and balance sheet for 2017. Furthermore, it was decided that the company’s results shall be carried forward and thus no dividend will be

Record 5,200 tonne megatrain transports SSAB’s steel from Raahe to Hämeenlinna

The largest Finnish freight train in terms of volume started in regular traffic between Raahe and Hämeenlinna on April 30. This 5,200 tonne megatrain carries steel coils from Raahe to Hämeenlinna. Earlier, two trains a day transported steel coils, but from now on just one train will do the job. SSAB and VR Transpoint have created a new highly efficient business model for transporting steel coils between the two sites. Whereas earlier two trains a day were needed to transport steel coils from Raahe to Hämeenlinna, the job can now be done by just one megatrain. Fully loaded, the

Bulletins from the Annual General Meeting

PRESSRELEASE 2017-05-04 The annual general meeting of Axactor AB (publ) was held at MAQS Advokatbyrås office, Mäster Samuelsgatan 20 in Stockholm on May 4, 2018. Lawyer Partik Essehorn was elected chairman of the meeting. During the meeting CEO Endre Rangnes gave a presentation of the 2017 financial year and the current status of Axactor AB (publ). The meeting, amongst other things, decided on the following matters: Members of the board, deputy member of the board and remuneration to the board of directorsIt was resolved to re-elect the Bjørn Erik Næss (board member), Beate

Bulletins from the Annual General Meeting

PRESSRELEASE 2017-05-04 The annual general meeting of Axactor AB (publ) was held at MAQS Advokatbyrås office, Mäster Samuelsgatan 20 in Stockholm on May 4, 2018. Lawyer Partik Essehorn was elected chairman of the meeting. During the meeting CEO Endre Rangnes gave a presentation of the 2017 financial year and the current status of Axactor AB (publ). The meeting, amongst other things, decided on the following matters: Members of the board, deputy member of the board and remuneration to the board of directorsIt was resolved to re-elect the Bjørn Erik Næss (board member), Beate

Invitation to Q1 2018 presentation on May 9, following the Annual General Meeting

Cxense ASA will hold its Annual General Meeting on May 9 2018 at 08:30 am CET at the Felix Conference Center, Bryggetorget 3, Oslo, Norway. The company will present its Q1 2018 results at 09:00 am CET or after the AGM has been adjourned. The Q1 presentation will also be held at Felix Konferansesenter and a live webcast will be available at: http://webtv.hegnar.no/presentation.php?webcastId=83481704 Investor Relations Contact: Jørgen Loeng, Chief Financial Officer Email: ir@cxense.com Mobile: +47 90 66 00 62

Proposals from the Nomination Committee to the Annual General Meeting in Cxense ASA

Reference is made to the stock exchange announcement from Cxense ASA (the "Company") on 17 April 2018 regarding the annual general meeting in the Company to be held on 9 May 2018. Please find enclosed the proposal from the Nomination Committee to the annual general meeting. The proposal will also be made available at the Company's website, www.cxense.com. Investor Relations Contact: Jørgen Loeng, Chief Financial OfficerEmail: ir@cxense.comMobile: +47 90 66 00 62

YIT Corporation: Managers’ transactions

YIT Corporation Managers' transactions May 4, 2018 at 11:55 a.m.____________________________________________ Person subject to the notification requirementName: Kauniskangas, KariPosition: Chief Executive OfficerIssuer: YIT PlcLEI: 529900M13GM4VSTE6W80 Notification type: INITIAL NOTIFICATION Reference number: 529900M13GM4VSTE6W80_20180504104111_31 ____________________________________________ Transaction date: 2018-05-03Instrument type: SHAREISIN: FI0009800643Nature of the transaction: RECEIPT OF A SHARE-BASED INCENTIVE Transaction details(1): Volume: 15500

Peab expands Olskroken for the Swedish Transport Administration for SEK 2,900 million

Peab has been commissioned to expand one of the most important junctions in the West Sweden railroad system, Olskroken, with railway track overpasses. The customer is the Swedish Transport Administration and the contract is worth SEK 2,900 million.The construction contract for Olskroken is divided into two phases. In the first phase, which began in December 2015, Peab and the Swedish Transport Administration have worked together on planning and producing a target price for the project. Now Peab has been awarded the contract for the second phase which is a turnkey contract that includes

Double Bond aims on adaptive design for SI-053 Phase I

Double Bond Pharmaceutical (DBP) has signed a service contract with Cytel Inc, a leading provider of clinical research services and software, to develop an adaptive model-based study design for upcoming Phase I clinical trial for SI-053. “In our planned Phase I dose-escalation study we aim on using an adaptive model-based design to help identify the maximum tolerated dose (MTD) of SI-053, - says Dr Breezy Lindqvist, CMO of DBP. - This is considered to be much more effective than the traditional 3+3 model and is a crucial step in the clinical development of SI-053, as it also decides the

Raisio plc: Raisio Group’s cooperation negotiations entirely completed

Raisio plc, Stock Exchange Release, 4 May 2018 RAISIO GROUP'S COOPERATION NEGOTIATIONS ENTIRELY COMPLETED On Friday 4 May 2018, the Raisio Group announced the divestment of its cattle feed business to Lantmännen Agro Oy. With the deal, Raisio has also completed the cooperation negotiations still open in terms of employments closely related to Raisioagro. As a result of the negotiations started in January 2018, a total of 22 employments will be terminated. As an interim decision for the negotiations, the company announced already in March to terminate 20 employments. After the

Edison - an Investment Research Company - has taken up coverage of the Oncology Venture share

Please visit Edison to read their initiation report: link   For further information about Oncology Venture, please contact: Ulla Hald Buhl, COO and Chief IR & or Peter Buhl Jensen, CEOMobile: +45 21 60CommunicationsMobile: +45 2170 89 22E-mail: pbj@oncologyventure.com  1049uhb@oncologyventure.com About Oncology Venture Sweden AB  Oncology Venture Sweden AB is engaged in the research and development of anti-cancer drugs via its wholly owned Danish subsidiary Oncology Venture ApS. Oncology Venture has a license to use Drug

Fazer Experience wins architecture prize

The Fazer Experience Visitor Centre in Vantaa, Finland has been awarded the Vuoden Lasirakenne 2018 award for best glass structure. The prize is awarded every two years by Suomen Tasolasiyhdistys ry, an association of companies in the plate glass sector in Finland. According to the jury, Fazer has understood well the added value that impressive architecture can bring to a business. Thanks to its glass structure, the Fazer Experience Visitor Centre has a light and elegant appearance in a variety of lighting conditions. The overall result is a stylish, balanced and inviting structure. This is

Samuli Eskola new CEO for chicken producer Naapurin Maalaiskana

Scandi Standard welcomes Samuli Eskola as new CEO and Country Manager for Finland. Eskola has close to 20 years of FMCG experience in leading positions from listed Nordic food companies, like Atria, Apetit, HKScan and latest as the CEO of Polarica Group.Samuli Eskola takes over from Jyrki Heinimo who has lead Naapurin Maalaiskana Oy as an interim CEO since July 2017. During this time the Finnish business has had a growth of over 20 percent, close to 10 million € on an annualized basis and has made a significant contribution towards break even. Samuli Eskola has solid experience from the

LINK Mobility partners with Loop AI Labs to introduce the next generation of artificial intelligence services

LINK Mobility has entered into an agreement with the San Francisco based Loop AI Labs to embed advanced artificial intelligence capabilities into its platform, making LINK Mobility the smartest mobile services and solutions provider in Europe.SAN FRANCISCO 4th May 2018 Today LINK Mobility, the leading European provider of mobile messaging and solutions, enters into an agreement with Loop AI Labs, a leading provider of unsupervised cognitive computing. The partnership will bring the power of cognitive computing and artificial intelligence to LINK’s 16 500 Enterprise and Small Medium

Share buy-backs in Telia Company to cover commitments under the ‘Long Term Incentive Program 2015/2018’

On 3 May 2018, Telia Company AB (publ) (LEI code 213800FSR9RNDUOTXO25) has repurchased in total 445 891 own shares (ISIN: SE0000667925) as part of the share buy-back programme initiated by the Board of Directors to cover commitments under the “Long Term Incentive Program 2015/2018” approved by the Annual General Meeting 2015. The share buy-back programme, which Telia Company announced on 27 April 2018, is being carried out in accordance with the Market Abuse Regulation (EU) No 596/2014 (”MAR”) and the Commission Delegated Regulation (EU) No 2016/1052 (the “Safe Harbour Regulation”). The

Scientific Publication on Clinical Studies of VAL001

Respiratorius announces that the high-ranking scientific journal of the American Society of Hematology – Blood Advances, accepted the manuscript "Valproate in Combination with Rituximab and CHOP as First Line Therapy in Diffuse Large B-cell Lymphoma (VALFRID)" for immediate publication.The scientific article summarizes the implementation and results of the study. The key results from the Phase I / IIa stuies are presented briefly: · •      Potential synergistic effect with Rituximab as VAL001 increases the levels of the surface protein CD20. · •      Overall Survival Analysis for

Bactiguard appoints new distributor in Mexico

Bactiguard signs distribution agreement for Mexico with Degasa, a well-established family owned company in the second largest market in Latin America.“Degasa is a strong distributor in the attractive Mexican market, with both the resources and competence required to drive a successful market introduction”, says Christian Kinch, CEO at Bactiguard. Mexico in the second largest market in Latin America with its 120 million inhabitants, only succeeded by Brazil. Degasa is a family owned company with no less than 10 country-wide sales offices that cover the entire country, and are well

Continued patient treatments in clinical trial

A further two patients were treated 3rd May in SpectraCure's clinical trial for treatment of recurrent prostate cancer at the Princess Margaret Cancer Centre in Toronto. The treatments were done with the method based on photodynamic therapy (PDT) developed by SpectraCure. As before, the treatments were performed by a team led by Drs Neil Fleshner and Nathan Perlis and everything passed well, the company's technology worked well according to plans and patients are doing well. "It is very pleasing that we have been able to treat two patients in one day. This is an important step in order

Change in number of shares in Parans Solar Lighting AB (publ)

Conversion of convertible notes into shares under the financing agreement announced on November 21st2017 and the Amendment Agreement announced on March 9th 2018.The date of conversion was May 3rd 2018 and the number of Notes converted was 50. The number of Notes remaining under the second conversion in the second tranche for future conversion is 100. The number of shares and the number of votes before the conversion was       20 283 600. Through the conversion the number of shares and the number of votes has increased by 188 679. The total number of shares and the total number of votes

There are no items matching the current filter
There are no more items matching the current filter
Back to top